The study by Honda et al., conducted in 2017, was an open-label, single-arm, multicentre pilot study that evaluated the therapeutic effect of oral glutathione administration (300 mg/day) in patients with NAFLD through the evolution of biochemical indices (ALT) and liver fat levels assessed by VCTE (79)
Your Health Magazine Contributor More Health News & Research Articles BPC-157 Canada Research Guide 2026: Sourcing, Research, and Compliance DISCLOSURE: This article contains sponsored links and was published as sponsored content
Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID-19 patients
He, Y., Zhao, Y., Zhang, C., Sun, C
Levagen+ is a brand name of ultra-micronized PEA that was used in some of the clinical trials (especially in Australia)